Diploma PLC (LON:DPLM – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight research firms that are presently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is GBX 7,400.
Several research analysts have commented on the company. Berenberg Bank reaffirmed a “buy” rating and set a GBX 9,000 target price on shares of Diploma in a report on Monday, July 20th. Jefferies Financial Group restated a “hold” rating and set a GBX 7,000 price objective on shares of Diploma in a research report on Friday, May 29th. Royal Bank Of Canada reissued an “outperform” rating and set a GBX 7,400 target price on shares of Diploma in a research report on Tuesday, September 8th. Finally, JPMorgan Chase & Co. raised their price target on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a report on Monday, August 24th.
Get Our Latest Research Report on DPLM
Diploma Price Performance
Insider Transactions at Diploma
In other news, insider Mandy Gradden purchased 1,000 shares of the business’s stock in a transaction on Friday, July 17th. The shares were acquired at an average price of GBX 7,183 per share, with a total value of £71,830. Also, insider Katie Bickerstaffe purchased 246 shares of the firm’s stock in a transaction on Wednesday, September 23rd. The shares were acquired at an average price of GBX 7,696 per share, with a total value of £18,932.16. Insiders bought a total of 1,850 shares of company stock worth $13,340,934 over the last three months. 1.14% of the stock is owned by company insiders.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
See Also
- Five stocks we like better than Diploma
- Dave’s Success Has Investors Split
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
